Search results

Skip to results

Area of interest

Area of interest

Type

Type

Status

Status

Last updated

Last updated

Guidance programme

Advice programme

Showing 76 to 90 of 5124 results for technology

  1. Psychological interventions: What is the effectiveness of specific psychological interventions including digital compared with face-to-face (technology use) in different populations and settings?

    psychological interventions including digital compared with face-to-face (technology use) in different populations and settings? Any...

    Research recommendation
    Published
    30 September 2022

  2. Behaviour change: digital and mobile health interventions (NG183)

    This guideline covers interventions that use a digital or mobile platform to help people eat more healthily, become more active, stop smoking, reduce their alcohol intake or practise safer sex. The interventions include those delivered by text message, apps, wearable devices or the internet. The guideline only includes those that are delivered by the technology itself and not by healthcare professionals using technology to deliver interventions.

    NICE guideline
    Published
    7 October 2020
    View recommendations

    Sections for NG183

  3. Health technology evaluations: interim methods and process guide for the proportionate approach to technology appraisals (PMG40)

    This interim methods and process guide for the proportionate approach to technology appraisals has been incorporated into NICE health technology evaluations: the manual.

  4. Digital health technologies: What is the clinical and cost effectiveness of digital health technologies in people with epilepsy?

    Question Digital health technologies: What is the clinical and cost effectiveness of digital health technologies in people...

    Research recommendation
    Published
    11 May 2022

  5. Rucaparib for maintenance treatment of relapsed platinum-sensitive ovarian, fallopian tube or peritoneal cancer (Review of TA611) [ID4069]

    In development [GID-TA10985] Expected publication date: 12 June 2024

    Technology appraisal guidance
    In development

  6. Ganaxolone for treating seizures caused by CDKL5 deficiency disorder in people 2 years and over [ID3988]

    In development [GID-TA10948] Expected publication date: 26 June 2024

    Technology appraisal guidance
    In development

  7. Liposomal bupivacaine for treating postoperative pain [ID3799]

    The topic was stopped after scoping, this means the topic will not proceed to a Technology Appraisal   ...

    Technology appraisal guidance
    Topic selection

  8. Remote decision-support technologies:- Are paramedic remote decision-support technologies clinically and cost effective? [See the evidence review on paramedic remote support.]

    Question Remote decision-support technologies:- Are paramedic remote decision-support technologies clinically and cost...

    Research recommendation
    Published
    21 November 2018

  9. Remimazolam for sedation for people having diagnostic or therapeutic procedures [ID3758]

    The topic was stopped after scoping, this means the topic will not proceed to a Technology Appraisal   ...

    Technology appraisal guidance
    Topic selection

  10. MolecuLight i:X for wound imaging

    The panel agreed the technology is not appropriate to be selected for guidance development as there is insufficient evidence.   ...

    Medical technologies guidance
    Topic selection

  11. More research is needed on using the following digital weight-management technologies:

    weight-management technologies: Any explanatory notes(if applicable) CheqUp (CheqUp Health) Juniper (Juniper Technologies...

    Research recommendation
    Published
    11 January 2024

  12. Effectiveness of digital technologies:- How effective and cost effective are digital technologies, such as web-based interventions, online self-assessment or targeted new media, for drug misuse prevention among groups at risk in the UK?

    Question Effectiveness of digital technologies:- How effective and cost effective are digital technologies, such as...

    Research recommendation
    Published
    4 May 2017

  13. There have been no head-to-head trials of rivaroxaban compared with a low molecular weight heparin for people who have cancer and experience an acute pulmonary embolism or deep vein thrombosis. As in NICE technology appraisal guidance 261 it is recommended that further research should be carried out.

    experience an acute pulmonary embolism or deep vein thrombosis. As in NICE technology appraisal guidance 261 it is recommended that...

    Research recommendation
    Published
    9 June 2015

  14. Nitisinone for treating alkaptonuria [ID2691]

    The topic was stopped after scoping, this means the topic will not proceed to a Technology Appraisal   ...

    Technology appraisal guidance
    Topic selection

  15. Isatuximab with pomalidomide and dexamethasone for treating relapsed and refractory multiple myeloma [Review of TA658] [ID4067]

    In development [GID-TA10979] Expected publication date: 26 June 2024

    Technology appraisal guidance
    In development